CPPD - Calcium Pyrophosphate Deposition Disease, Gitelman Syndrome
Conditions
Brief summary
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.
Detailed description
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for calcium pyrophosphate deposition, and the clinical data and radiographic manifestations are collected and analyzed to investigate the osteoarticular features in patients with Gitelman Syndrome.
Interventions
DIAGNOSTIC_TESTconventional radiograph or computed tomography
patients with gitelman syndrome evaluated with conventional radiograph or computed tomography
Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients confirmed with Gitelman Syndrome
Exclusion criteria
* Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The presence of chondrocalcinosis | From the enrollment to the performance of the CPPD screen | The presence of chondrocalcinosis on conventional radiograph or computed tomography in patients with Gitelman Syndrome |
Countries
China
Contacts
Primary ContactLijun Mou
Outcome results
None listed